Solventum Corp | SOLV - Sales Revenues

Stock Price
77.04
Daily Change
0.55 0.72%
Monthly
-7.36%
Yearly
3.02%
Q1 Forecast
74.60

Solventum Corp reported $2.1B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Align Technology USD 1.05B 54.3M Dec/2025
Baxter International USD 2.84B 30M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Cencora USD 85.9B 5.2B Sep/2025
Dexcom USD 1.21B 50M Sep/2025
Insulet USD 706.3M 57.2M Sep/2025
Solventum Corp USD 2.1B 60M Sep/2025
West Pharmaceutical Services USD 804.6M 38.1M Sep/2025
Zimmer Biomet Holdings USD 2B 80M Sep/2025